Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge

Schizophr Res. 2020 Jun:220:265-266. doi: 10.1016/j.schres.2020.04.030. Epub 2020 Apr 27.

Authors

Petru Ifteni¹, Lorena Dima², Andreea Teodorescu³

Affiliations

¹ Transilvania University of Brasov, Romania; Clinical Hospital of Psychiatry and Neurology Brasov, Romania. Electronic address: petru.ifteni@unitbv.ro.
² Transilvania University of Brasov, Romania. Electronic address: lorena.dima@unitbv.ro.
³ Transilvania University of Brasov, Romania; Clinical Hospital of Psychiatry and Neurology Brasov, Romania. Electronic address: andreea.teodorescu@unitbv.ro.

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents / administration & dosage*
COVID-19
Communicable Disease Control*
Coronavirus Infections* / prevention & control
Delayed-Action Preparations / administration & dosage*
Drug Prescriptions / statistics & numerical data*
Humans
Injections
Medication Adherence*
Pandemics* / prevention & control
Pneumonia, Viral* / prevention & control
Romania
Schizophrenia / drug therapy*

Substances

Antipsychotic Agents
Delayed-Action Preparations